Actively Recruiting
Spatially Transcriptomics Reveals Molecular Signatures in CRPS
Led by Seoul National University · Updated on 2024-05-29
10
Participants Needed
1
Research Sites
76 weeks
Total Duration
On this page
Sponsors
S
Seoul National University
Lead Sponsor
H
Hanyang University
Collaborating Sponsor
AI-Summary
What this Trial Is About
This observational study aims to understand phenotype-specific molecular signatures in patients with complex regional pain syndrome (CRPS).
CONDITIONS
Official Title
Spatially Transcriptomics Reveals Molecular Signatures in CRPS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meets the Budapest diagnostic criteria
- Consents to participation in this study
- Aged between 19 and 80 years old
- Symptoms and/or signs of sensory, vasomotor, and sudomotor changes
You will not qualify if you...
- Does not agree to participate in this study
- Has contraindications for skin punch biopsy such as thrombocytopenia or taking anticoagulant drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National University Hospital
Seoul, South Korea
Actively Recruiting
Research Team
J
Jee Youn Moon, MD, PhD
CONTACT
J
Jeongsoo Kim, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here